Sun Pharma to Acquire Checkpoint Therapeutics
Press Releases

Sun Pharma to Acquire Checkpoint Therapeutics

Will add UNLOXCYT™ (cosibelimab-ipdl), the first and only FDA-approved anti-PD-L1 treatment for

logo salamanca press

Salamanca Press

Local & Social